Wanyi Medical's Hong Kong IPO Prospectus Expires on July 1 After Six Months

According to Zhitong Finance, Shanghai Wanyi Medical Technology's Hong Kong IPO prospectus, submitted on January 1, 2026, expired on July 1, 2026, having reached the six-month validity period. Everbright Securities International served as the exclusive sponsor for the listing.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments